Thomasville National Bank cut its holdings in Pfizer Inc. (NYSE:PFE – Get Rating) by 9.9% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 94,513 shares of the biopharmaceutical company’s stock after selling 10,363 shares during the quarter. Thomasville National Bank’s holdings in Pfizer […]
Aurora Private Wealth Inc. cut its holdings in Pfizer Inc. (NYSE:PFE – Get Rating) by 4.4% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 17,621 shares of the biopharmaceutical company’s stock after selling 818 shares during the period. Aurora Private Wealth […]
Gofen & Glossberg LLC IL lessened its holdings in Pfizer Inc. (NYSE:PFE – Get Rating) by 2.0% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 382,756 shares of the biopharmaceutical company’s stock after selling 7,732 shares during the period. Gofen & Glossberg LLC IL’s holdings in Pfizer […]
CNB Bank trimmed its holdings in shares of Pfizer Inc. (NYSE:PFE – Get Rating) by 1.0% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 68,809 shares of the biopharmaceutical company’s stock after selling 724 shares during the period. Pfizer makes up about 2.0% of […]
Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Get Rating) Director Robert J. Gould sold 24,382 shares of the business’s stock in a transaction on Monday, June 6th. The stock was sold at an average price of $8.10, for a total value of $197,494.20. Following the completion of the transaction, the director now owns 506,630 shares of the […]